TUHURA BIOSCIENCES INC (HURA) Stock Fundamental Analysis

NASDAQ:HURA • US8989201038

1.68 USD
+0.28 (+20%)
At close: Feb 25, 2026
1.68 USD
0 (0%)
After Hours: 2/25/2026, 8:18:50 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

Overall HURA gets a fundamental rating of 1 out of 10. We evaluated HURA against 521 industry peers in the Biotechnology industry. HURA may be in some trouble as it scores bad on both profitability and health. HURA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • HURA had negative earnings in the past year.
  • HURA had a negative operating cash flow in the past year.
  • HURA had negative earnings in each of the past 5 years.
  • In the past 5 years HURA always reported negative operating cash flow.
HURA Yearly Net Income VS EBIT VS OCF VS FCFHURA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -170.33%, HURA is doing worse than 86.18% of the companies in the same industry.
  • With a Return On Equity value of -260.88%, HURA is not doing good in the industry: 71.59% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -170.33%
ROE -260.88%
ROIC N/A
ROA(3y)-224%
ROA(5y)-257.81%
ROE(3y)-832.26%
ROE(5y)-1280.11%
ROIC(3y)N/A
ROIC(5y)N/A
HURA Yearly ROA, ROE, ROICHURA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1K -2K -3K

1.3 Margins

  • HURA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HURA Yearly Profit, Operating, Gross MarginsHURA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • The number of shares outstanding for HURA has been reduced compared to 1 year ago.
  • Compared to 5 years ago, HURA has more shares outstanding
  • There is no outstanding debt for HURA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HURA Yearly Shares OutstandingHURA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
HURA Yearly Total Debt VS Total AssetsHURA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

  • HURA has an Altman-Z score of -6.87. This is a bad value and indicates that HURA is not financially healthy and even has some risk of bankruptcy.
  • HURA has a worse Altman-Z score (-6.87) than 65.45% of its industry peers.
  • A Debt/Equity ratio of 0.03 indicates that HURA is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.03, HURA is in line with its industry, outperforming 43.19% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -6.87
ROIC/WACCN/A
WACCN/A
HURA Yearly LT Debt VS Equity VS FCFHURA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

2.3 Liquidity

  • A Current Ratio of 0.40 indicates that HURA may have some problems paying its short term obligations.
  • The Current ratio of HURA (0.40) is worse than 91.17% of its industry peers.
  • A Quick Ratio of 0.40 indicates that HURA may have some problems paying its short term obligations.
  • HURA has a Quick ratio of 0.40. This is amonst the worse of the industry: HURA underperforms 90.60% of its industry peers.
Industry RankSector Rank
Current Ratio 0.4
Quick Ratio 0.4
HURA Yearly Current Assets VS Current LiabilitesHURA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 65.62% over the past year.
EPS 1Y (TTM)65.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.78%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 32.17% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-36.96%
EPS Next 2Y-4.26%
EPS Next 3Y-8.03%
EPS Next 5Y32.17%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HURA Yearly Revenue VS EstimatesHURA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M 500M
HURA Yearly EPS VS EstimatesHURA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -2K -4K -6K -8K -10K

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for HURA. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HURA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HURA Price Earnings VS Forward Price EarningsHURA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HURA Per share dataHURA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

  • A cheap valuation may be justified as HURA's earnings are expected to decrease with -8.03% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.26%
EPS Next 3Y-8.03%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for HURA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TUHURA BIOSCIENCES INC

NASDAQ:HURA (2/25/2026, 8:18:50 PM)

After market: 1.68 0 (0%)

1.68

+0.28 (+20%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-14
Earnings (Next)N/A
Inst Owners10.19%
Inst Owner Change4.01%
Ins Owners28.63%
Ins Owner ChangeN/A
Market Cap102.01M
Revenue(TTM)N/A
Net Income(TTM)-43.77M
Analysts82.22
Price Target9.24 (450%)
Short Float %7.27%
Short Ratio1.9
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)-52.55%
DP-0.01%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-23.75%
Min EPS beat(2)-62.53%
Max EPS beat(2)15.03%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.23%
EPS NQ rev (1m)3.7%
EPS NQ rev (3m)8.77%
EPS NY rev (1m)0%
EPS NY rev (3m)3.82%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 6.08
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.6
EYN/A
EPS(NY)-0.51
Fwd EYN/A
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)-0.57
OCFYN/A
SpS0
BVpS0.28
TBVpS-0.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -170.33%
ROE -260.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-224%
ROA(5y)-257.81%
ROE(3y)-832.26%
ROE(5y)-1280.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 58.02%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.4
Quick Ratio 0.4
Altman-Z -6.87
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)139.9%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.78%
EPS Next Y-36.96%
EPS Next 2Y-4.26%
EPS Next 3Y-8.03%
EPS Next 5Y32.17%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-407.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-906.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-903.22%
OCF growth 3YN/A
OCF growth 5YN/A

TUHURA BIOSCIENCES INC / HURA FAQ

What is the fundamental rating for HURA stock?

ChartMill assigns a fundamental rating of 1 / 10 to HURA.


What is the valuation status for HURA stock?

ChartMill assigns a valuation rating of 0 / 10 to TUHURA BIOSCIENCES INC (HURA). This can be considered as Overvalued.


Can you provide the profitability details for TUHURA BIOSCIENCES INC?

TUHURA BIOSCIENCES INC (HURA) has a profitability rating of 0 / 10.


How sustainable is the dividend of TUHURA BIOSCIENCES INC (HURA) stock?

The dividend rating of TUHURA BIOSCIENCES INC (HURA) is 0 / 10 and the dividend payout ratio is -0.01%.